Profile data is unavailable for this security.
About the company
Liaoning Cheng Da Co Ltd is a China-based company primarily engaged in trading businesses. The Company mainly operates four businesses. The pharmaceutical and healthcare business is mainly engaged in the research, development, production, and sale of human vaccines, as well as the provision of medical services. The financial investment business is mainly engaged in long-term investments and fund management. The domestic and international trade business is primarily engaged in the export of textiles and apparel, and the trading of commodities such as steel, coal, and grain. The energy development business is mainly involved in the mining of oil shale and the production and sales of shale oil. The Company conducts its businesses within domestic and overseas markets.
- Revenue in CNY (TTM)11.12bn
- Net income in CNY862.79m
- Incorporated1993
- Employees3.32k
- LocationLiaoning Cheng Da Co LtdNo. 71 Renmin Road, Zhongshan DistrictDALIAN 116001ChinaCHN
- Phone+86 41 182512731
- Fax+86 41 182691187
- Websitehttps://www.chengda.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.74bn | 1.23bn | 17.04bn | 3.41k | 13.87 | 2.39 | -- | 6.22 | 0.6271 | 0.6271 | 1.40 | 3.64 | 0.3589 | 1.05 | 5.11 | 803,924.60 | 15.84 | 14.89 | 17.08 | 15.68 | 71.05 | 78.86 | 44.15 | 35.26 | 3.49 | -- | 0.0988 | 50.60 | -34.66 | -6.27 | -103.66 | -- | 14.17 | 4.56 |
| Jinyu Bio-Technology Co Ltd | 1.33bn | 100.76m | 17.24bn | 1.74k | 218.45 | 3.15 | -- | 12.99 | 0.071 | 0.071 | 1.27 | 4.92 | 0.1946 | 2.45 | 1.89 | 762,676.30 | 1.37 | 4.31 | 1.56 | 5.06 | 50.46 | 57.76 | 7.02 | 17.99 | 3.09 | -- | 0.0029 | 36.89 | -21.45 | 2.19 | -61.57 | -13.19 | -21.84 | -12.94 |
| Shandong Buchang Pharmaceuticals Co Ltd | 10.96bn | 1.66m | 17.80bn | 7.69k | 2,475.07 | 1.68 | -- | 1.62 | 0.0068 | 0.0068 | 10.34 | 10.03 | 0.5519 | 0.9196 | 13.73 | 1,425,409.00 | -0.6503 | 0.8521 | -0.9366 | 1.25 | 62.31 | 70.57 | -1.18 | 1.32 | 0.4929 | 3.23 | 0.2758 | 157.32 | -16.91 | -5.04 | -273.62 | -- | -21.53 | -- |
| Liaoning Cheng Da Co Ltd | 11.12bn | 862.79m | 17.88bn | 3.32k | 20.33 | 0.6079 | -- | 1.61 | 0.575 | 0.575 | 7.27 | 19.23 | 0.2277 | 5.72 | 5.88 | 3,352,748.00 | 2.94 | 3.15 | 4.13 | 4.55 | 12.07 | 13.95 | 12.89 | 9.88 | 0.9357 | -- | 0.2586 | 16.44 | 4.70 | -8.65 | -10.09 | -29.33 | -9.31 | -27.52 |
| China Resources Dubl-Crne Phrmctl Co Ltd | 10.95bn | 1.58bn | 19.02bn | 13.41k | 11.95 | 1.68 | -- | 1.74 | 1.53 | 1.53 | 10.62 | 10.90 | 0.6524 | 2.99 | 5.05 | 816,058.20 | 9.70 | 8.90 | 13.45 | 11.99 | 56.61 | 57.39 | 14.86 | 13.13 | 1.75 | -- | 0.0904 | 33.53 | -0.8711 | 3.63 | -2.19 | 9.06 | 21.41 | 9.15 |
| BrightGene Bio-Medical Technology Co Ltd | 1.18bn | 62.08m | 19.18bn | 1.15k | 304.44 | 7.84 | -- | 16.26 | 0.1489 | 0.1489 | 2.82 | 5.79 | 0.2305 | 1.61 | 3.38 | 1,025,174.00 | 0.5058 | 5.25 | 0.6383 | 6.47 | 51.53 | 56.22 | 2.19 | 17.55 | 0.9402 | 1.23 | 0.4935 | 21.32 | 8.74 | 20.58 | -6.57 | 11.23 | 23.50 | 3.20 |
Data as of Feb 13 2026. Currency figures normalised to Liaoning Cheng Da Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 14.21m | 0.93% |
| First Seafront Fund Management Co., Ltd.as of 31 Mar 2025 | 8.89m | 0.58% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 5.51m | 0.36% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 4.17m | 0.27% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 4.15m | 0.27% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 4.13m | 0.27% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 2.43m | 0.16% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 2.36m | 0.15% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.31m | 0.15% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.96m | 0.13% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
